Form 4 for RGEN REPLIGEN CORP
Accepted 2023-03-06 00:00:00 ET · period of report 2023-03-02 · accession 0000899243-23-007201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-06 | 2023-03-02+ | RGEN | Snodgres Jon | CFO | A - Grant | $0.00 | +13.6K | 33.0K | +71% | $0 |
| D | 2023-03-06 | 2023-03-03 | RGEN | Snodgres Jon | CFO | F - Tax | $188.00 | -3,674 | 38.1K | -9% | -$690.7K |
| D | 2023-03-06 | 2023-03-02 | RGEN | Snodgres Jon | CFO | A - Grant | $0.00 | +5,019 | 5,019 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-03 | A | A | 8,795 | $0.00 | 41,765 | D | — | — | (F2) Represents 625 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2022, and 8,170 shares issued pursuant to a PSU award granted to the Issuer on February 27, 2020. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU awards. |
| 2 | Common | Common Stock | 2023-03-03 | F | D | 3,674 | $188.00 | 38,091 | D | — | — | (F3) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs. |
| 3 | Common | Common Stock | 2023-03-02 | A | A | 4,848 | $0.00 | 32,970 | D | — | — | (F1) Mr. Snodgres was awarded 4,848 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-03-02 | A | A | 5,019 | $0.00 | 5,019 | D | $180.48 · — to 2033-03-02 | 5,019 Common Stock | (F4) One third of the stock options will vest and become exercisable annually on March 2, 2024, March 2, 2025, and March 2, 2026. |